RESUMEN
BACKGROUND: Recurrent stress urinary incontinence (SUI) following male sling can be managed surgically with artificial urinary sphincter (AUS) insertion. Prior small, single-center retrospective studies have not demonstrated an association between having failed a sling procedure and worse AUS outcomes. The aim of this study was to compare outcomes of primary AUS placement in men who had or had not undergone a previous sling procedure. METHODS: A retrospective review of all AUS devices implanted at a single academic center during 2000-2018 was performed. After excluding secondary AUS placements, revision and explant procedures, 135 patients were included in this study, of which 19 (14.1%) patients had undergone prior sling procedures. RESULTS: There was no significant difference in demographic characteristics between patients undergoing AUS placement with or without a prior sling procedure. Average follow up time was 28.0 months. Prior sling was associated with shorter overall device survival, with an increased likelihood of requiring revision or replacement of the device (OR 4.2 (1.3-13.2), p = 0.015) as well as reoperation for any reason (OR 3.5 (1.2-9.9), p = 0.019). While not statistically significant, patients with a prior sling were more likely to note persistent incontinence at most recent follow up (68.8% vs. 42.7%, p = 0.10). CONCLUSIONS: Having undergone a prior sling procedure is associated with shorter device survival and need for revision or replacement surgery. When considering patients for sling procedures, patients should be counseled regarding the potential for worse AUS outcomes should they require additional anti-incontinence procedures following a failed sling.
RESUMEN
PURPOSE: Artificial urinary sphincters (AUS) remain the gold standard to treat male stress urinary incontinence. AUS implantation can be performed through a penoscrotal or perineal incision depending on surgeon preference. METHODS: The present study compares initial AUS implantation through two surgical approaches focusing on outcomes of continence and revision. All AUS implanted at an academic medical center between 2000 and 2018 were retrospectively reviewed. RESULTS: A total of 225 AUS implantations were identified, of which, 114 patients who underwent virgin AUS placement were included in the study with a mean follow-up of 28.5 months. A total of 68 patients (59.6%) had AUS placement through penoscrotal incision; while, 46 (40.4%) had a perineal incision. While operative time was significantly shorter for penoscrotal placement (98.6 min vs. 136.3 min, p = 0.001), there were no significant differences in continence rates between either surgical approach with 76.5% socially continent defined as using zero to less than 1 pad per day (safety pad). The overall rate of device erosion or infection was not significantly different between groups. However, the rate of revision or replacement was significantly higher in the perineal group (26.1% v. 8.8%; p = 0.01). On multivariate analysis, the penoscrotal incision predicted a lower rate of device revision (p = 0.01). CONCLUSIONS: The penoscrotal approach of AUS placement is associated with shorter operative time. While we observed a lower revision rate compared to the perineal approach, there were equivalent continence outcomes.
Asunto(s)
Incontinencia Urinaria de Esfuerzo/cirugía , Esfínter Urinario Artificial , Anciano , Humanos , Masculino , Persona de Mediana Edad , Pene/cirugía , Perineo/cirugía , Implantación de Prótesis , Reoperación/estadística & datos numéricos , Estudios Retrospectivos , Escroto/cirugía , Resultado del Tratamiento , Procedimientos Quirúrgicos Urológicos Masculinos/métodosRESUMEN
OBJECTIVE: To evaluate how variations in peri-operative urine culture (UCx) and antibiotic prophylaxis utilization following robot assisted laparoscopic pyeloplasty (RALP) affect post-RALP urinary tract infection (UTI) rates in children, then use data to generate a standardized care pathway. METHODS: Patients undergoing RALP at a single institution from January 2014 to October 2018 were retrospectively reviewed. Patients with vesicoureteral reflux, neurogenic bladder, intermittent catheterization, <=2 months follow-up after stent removal, or age >=18 years were excluded. UCx use, UCx results, and pre- and post-RALP antibiotic use were recorded. The primary outcome was symptomatic UTI, tracked until 60 days after stent removal. UTI was defined as presence of fever or urinary symptoms, a positive UCx with >=10,000 colony forming units of one uropathogen, and a positive urinalysis. RESULTS: A total of 152 patients were included (72% male [73% circumcised], 61% white, and 23% Hispanic). One underwent a re-operative pyeloplasty, yielding 153 encounters. Eight patients (5.2%; 95% CI 1.7-8.7%) developed post-RALP UTI. Uncircumcised status and use of pre-operative prophylactic antibiotics were associated with post-RALP UTI (Pâ¯=â¯.03 and P < .01, respectively). Use of post-RALP antibiotics, whether prophylactic or therapeutic, was not associated with lower UTI rates (Pâ¯=â¯.92). Positive pre-RALP UCx and positive intra-operative stent removal UCx were associated with higher UTI rates (Pâ¯=â¯.03 and P < .01, respectively). CONCLUSION: UTI occurred in 5.2% of our cohort of >150 patients. As post-RALP antibiotic use was not associated with lower UTI rates, prophylactic antibiotics may be reserved for patients with risk factors. A standardized care pathway could safely reduce unnecessary utilization of UA/UCx and antibiotics.
Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Pelvis Renal/cirugía , Laparoscopía , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/microbiología , Procedimientos Quirúrgicos Robotizados , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Adolescente , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/orina , Estudios Retrospectivos , Urinálisis , Infecciones Urinarias/orina , Orina/microbiología , Procedimientos Quirúrgicos Urológicos/métodosRESUMEN
INTRODUCTION: Interviews are essential to the residency application process. Questions regarding marital status, childbearing, ethnicity and religion violate employment law if asked by the interviewer. In this study we determined rates of discriminatory questions asked during urology residency interviews and assessed for differences by applicant gender. METHODS: A 22-question anonymous survey was distributed to 340 urology residency applicants. Questions were asked in a 2-part, stepwise fashion. If candidates replied "no" to whether they introduced a restricted topic, they were subsequently asked how often interviewers introduced the topic. RESULTS: Overall 35% of respondents believed they were asked an inappropriate question. However, for the 7 restricted topics assessed in this survey 54.5% of respondents reported being asked at least 1 unprompted illegal question. Of note, 85% of female respondents vs 44.9% of male respondents reported being asked about 1 of the restricted topics from the survey (p <0.0001). Women were statistically more likely to be asked about age (33.3% vs 12.4%, p=0.0064), parental status (59.1% vs 31.1%, p=0.0172) and intent for children (41.9% vs 12.5%, p=0.0003). Men were more frequently asked about their opinions and rankings of other residency programs (51.6% vs 18.8%, p=0.0296). CONCLUSIONS: An alarming percentage of urology applicants are asked interview questions that violate employment law. Female applicants are disproportionately questioned about age, parental status and intent for children. Education of interviewers regarding legally restricted questions is warranted.
RESUMEN
INTRODUCTION AND OBJECTIVE: Studies have linked Black race to prostate cancer (CaP) risk but most fail to account for established risk factors such as 5-ARI use, prostate volume, socioeconomic status, and hospital setting. We assess whether Black race remains associated with CaP and Gleason ≥3â¯+â¯4 CaP, after adjusting for clinical setting and socioeconomic and clinical factors at prostate biopsy, with a focus on men aged 40-54 years, who may be excluded from current screening guidelines. METHODS: We recruited 564 men age 40-79 undergoing initial prostate biopsy for abnormal PSA or digital rectal examination (DRE) from three publicly funded and two private hospitals from 2009-2014. Univariate and multivariate analyses examined the associations between hospital type, race, West African Ancestry (WAA), clinical, and sociodemographic risk factors with CaP diagnosis and Gleason ≥3â¯+â¯4 CaP. Given changes in CaP screening recommendations, we also assess the multivariate analyses for men aged 40-54. RESULTS: Black and White men had similar age, BMI, and prostate volume. Black men had higher PSA (8.10 ng/mL vs. 5.63 ng/mL) and PSA density (0.22 ng/mL/cm3 vs. 0.15 ng/mL/cm3, all p < 0.001). Blacks had higher frequency of CaP (63.1% vs. 41.5%, p<0.001) and Gleason ≥3+4 CaP relative to Whites in both public (27.7% vs 11.6%, p<0.001) and private (48.4% vs 21.6%, pâ¯=â¯0.002) settings. In models adjusted for age, first degree family history, prostate volume, 5-ARI use, hospital type, income, marital and educational status, Black race was independently associated with overall CaP diagnosis (ORâ¯=â¯2.13, pâ¯=â¯0.002). There was a significant multiplicative interaction with Black race and abnormal DRE for Gleason ≥3â¯+â¯4 CaP (ORâ¯=â¯2.93, pâ¯=â¯0.01). WAA was not predictive of overall or significant CaP among Black men. Black race (OR = 5.66, pâ¯=â¯0.02) and family history (OR = 4.98, pâ¯=â¯0.01) were independently positively associated with overall CaP diagnosis for men aged 40 to 54. CONCLUSIONS: Black race is independently associated with CaP and Gleason ≥3+4 CaP after accounting for clinical and socioeconomic risk factors including clinical setting and WAA, and has a higher odds ratio of CaP diagnosis in younger men. Further investigation into optimizing screening in Black men aged 40 to 54 is warranted.
Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , Neoplasias de la Próstata/etnología , Adulto , Anciano , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Autoinforme , Factores SocioeconómicosRESUMEN
Vesicourethral anastomotic (VUA) disruption with bladder displacement into the abdominal cavity following robot-assisted laparoscopic prostatectomy (RALP) is an exceedingly rare complication. There have been no cited case reports after robotic surgery but case reports after open radical prostatectomy have been noted. Other complications related to VUA include bleeding with or without pelvic hematoma, bladder neck contracture, or severe stress urinary incontinence. Following radical prostatectomy, studies estimate the rate of VUA leakage to be 1.4% and no exact rate of complete disruption is known given its rarity. However, the majority of these cases are managed conservatively and rarely require reoperation. To date, there are no published studies that describe complete VUA and bladder displacement secondary to a large pelvic hematoma following prostatectomy. We report a rare case of VUA disruption after RALP successfully managed with conservative treatment.
RESUMEN
OBJECTIVE: To describe an anatomically correct simulator for use in suprapubic catheter (SPC) insertion training. METHODS: A scale reproduction of an adult male pelvis with bony landmarks and a subcutaneous fluid-filled reservoir was created using platinum cured silicone rubber. This model was evaluated by 6 expert urologists for content validity with a 16-item 5-point rating scale used to evaluate domains relevant to the simulatorphysical attributes, realism of experience, realism of materials, and global rating. The simulator was used by 25 general surgeons from rural practices participating in a 2-day comprehensive specialized surgical skills course. RESULTS: The domains were scored between 1 and 5; 1 being "not at all realistic" and 5 being "highly realistic, no changes needed." The average expert ratings of the domains were 3.9 (physical attributes), 4.3 (realism of experience), and 3.9 (realism of materials). The simulator was rated more valuable as a training tool (4.5) compared with a testing tool (3.8) with an average global rating of 4.1. CONCLUSION: Experts and trainees reported high satisfaction with their experience using this simulator. Preliminary evidence suggests this simulator is a useful tool that can be integrated into training programs to facilitate learning this necessary urologic skill.
Asunto(s)
Modelos Anatómicos , Cateterismo Urinario/métodos , Costos y Análisis de Costo , Humanos , Reproducibilidad de los Resultados , Encuestas y Cuestionarios , Urología/educaciónRESUMEN
The role of regulatory T cells (T(regs)) in human colon cancer (CC) remains controversial: high densities of tumor-infiltrating T(regs) can correlate with better or worse clinical outcomes depending on the study. In mouse models of cancer, T(regs) have been reported to suppress inflammation and protect the host, suppress T cells and protect the tumor, or even have direct cancer-promoting attributes. These different effects may result from the presence of different T(reg) subsets. We report the preferential expansion of a T(reg) subset in human CC with potent T cell-suppressive, but compromised anti-inflammatory, properties; these cells are distinguished from T(regs) present in healthy donors by their coexpression of Foxp3 and RORγt. T(regs) with similar attributes were found to be expanded in mouse models of hereditary polyposis. Indeed, ablation of the RORγt gene in Foxp3(+) cells in polyp-prone mice stabilized T(reg) anti-inflammatory functions, suppressed inflammation, improved polyp-specific immune surveillance, and severely attenuated polyposis. Ablation of interleukin-6 (IL-6), IL-23, IL-17, or tumor necrosis factor-α in polyp-prone mice reduced polyp number but not to the same extent as loss of RORγt. Surprisingly, loss of IL-17A had a dual effect: IL-17A-deficient mice had fewer polyps but continued to have RORγt(+) T(regs) and developed invasive cancer. Thus, we conclude that RORγt has a central role in determining the balance between protective and pathogenic T(regs) in CC and that T(reg) subtype regulates inflammation, potency of immune surveillance, and severity of disease outcome.